These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19437022)

  • 21. Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.
    Pilbrow AP; Lewis KA; Perrin MH; Sweet WE; Moravec CS; Tang WH; Huising MO; Troughton RW; Cameron VA
    Endocrinology; 2016 Dec; 157(12):4865-4874. PubMed ID: 27754786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress.
    Pournajafi-Nazarloo H; Partoo L; Sanzenbacher L; Azizi F; Carter CS
    Neuroendocrinology; 2007; 86(1):17-25. PubMed ID: 17551267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide urocortin 1 and its receptors are expressed in the human liver.
    Simopoulos C; Christodoulou E; Lambropoulou M; Tsaroucha AK; Kakolyris S; Polychronidis A; Karayiannakis AJ; Chatzaki E
    Neuroendocrinology; 2009; 89(3):315-26. PubMed ID: 19096201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
    Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
    J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions.
    Carrarelli P; Luddi A; Funghi L; Arcuri F; Batteux F; Dela Cruz C; Tosti C; Reis FM; Chapron C; Petraglia F
    Reprod Biomed Online; 2016 Oct; 33(4):476-483. PubMed ID: 27567427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues.
    Baigent SM; Lowry PJ
    J Mol Endocrinol; 2000 Aug; 25(1):43-52. PubMed ID: 10915217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
    Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
    Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.
    Chao H; Digruccio M; Chen P; Li C
    Endocrinology; 2012 Jan; 153(1):166-76. PubMed ID: 22067315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice.
    Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW
    Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence and distribution of urocortin and corticotrophin-releasing hormone receptors in the bovine thyroid gland.
    Squillacioti C; De Luca A; Alì S; Ciarcia R; Germano G; Vittoria A; Mirabella N
    Anat Histol Embryol; 2014 Dec; 43(6):429-34. PubMed ID: 24219151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro.
    Jin L; Zhang Q; Guo R; Wang L; Wang J; Wan R; Zhang R; Xu Y; Li S
    J Mol Endocrinol; 2011 Oct; 47(2):219-27. PubMed ID: 21765100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticotropin-releasing factor (CRF) system localization in human fetal heart.
    Chouridou E; Lambropoulou M; Koureta M; Zarouchlioti C; Balgouranidou I; Nena E; Papadopoulos N; Chatzaki E
    Hormones (Athens); 2016; 15(1):55-64. PubMed ID: 27377597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and role of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate corpus luteum during the menstrual cycle.
    Xu J; Xu F; Hennebold JD; Molskness TA; Stouffer RL
    Endocrinology; 2007 Nov; 148(11):5385-95. PubMed ID: 17690168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.
    Chao H; Li H; Grande R; Lira V; Yan Z; Harris TE; Li C
    Mol Endocrinol; 2015 Jun; 29(6):831-41. PubMed ID: 25875045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet.
    Jamieson PM; Cleasby ME; Kuperman Y; Morton NM; Kelly PA; Brownstein DG; Mustard KJ; Vaughan JM; Carter RN; Hahn CN; Hardie DG; Seckl JR; Chen A; Vale WW
    Diabetologia; 2011 Sep; 54(9):2392-403. PubMed ID: 21667214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urocortin protects chondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis?
    Intekhab-Alam NY; White OB; Getting SJ; Petsa A; Knight RA; Chowdrey HS; Townsend PA; Lawrence KM; Locke IC
    Cell Death Dis; 2013 Jul; 4(7):e717. PubMed ID: 23846219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separate locations of urocortin and its receptors in mouse testis: function in male reproduction and the relevant mechanisms.
    Tao J; Lin M; Sha J; Tan G; Soong TW; Li S
    Cell Physiol Biochem; 2007; 19(5-6):303-12. PubMed ID: 17495470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urocortin 1 inhibits rat leydig cell function.
    Rivier CL
    Endocrinology; 2008 Dec; 149(12):6425-32. PubMed ID: 18719027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of urocortin and corticotropin-releasing hormone receptors in the horse thyroid gland.
    Squillacioti C; De Luca A; Alì S; Paino S; Liguori G; Mirabella N
    Cell Tissue Res; 2012 Oct; 350(1):45-53. PubMed ID: 22684850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.
    Chen P; Vaughan J; Donaldson C; Vale W; Li C
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E337-45. PubMed ID: 19952342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.